Epidemiology of RSV Bronchiolitis Among Young Children in Central New York Before and After the Onset of the COVID-19 Pandemic
- PMID: 37725814
- DOI: 10.1097/INF.0000000000004101
Epidemiology of RSV Bronchiolitis Among Young Children in Central New York Before and After the Onset of the COVID-19 Pandemic
Abstract
Background: Respiratory syncytial virus (RSV) bronchiolitis is the leading cause of hospitalizations among infants in the United States. Unpredictability in RSV seasonality has occurred following the onset of the coronavirus disease 2019 (COVID-19) pandemic. Local surveillance networks can enhance the ability to appropriately time prophylaxis when exposure risk is highest.
Methods: A retrospective, cohort study was conducted to describe the epidemiologic patterns of RSV disease among outpatient, emergency department and inpatient encounters in children <5 years in Central New York before and after the onset of the COVID-19 pandemic. Local data were collected from October 2015 to January 2023 and compared to state-level data. Linear regression models were used to identify clinical and sociodemographic differences before and after the pandemic.
Results: Local variation in RSV seasonality was noted prior to the COVID-19 pandemic, however highly atypical circulation patterns appeared in the post-COVID-19 era. Since March 2020, patterns for local and state-defined RSV seasons have remained atypical (local season onset in 2021: week 27 and 2022: week 27; state season onset in 2021: week 31 and 2022: week 38). After adjusting for increases in testing, RSV bronchiolitis cases were not significantly different during pre- and post-pandemic eras. In comparison to the 2021 bronchiolitis season, the 2022 season had a higher proportion of RSV cases despite decreased testing.
Conclusions: Temporal patterns for RSV have shifted during the COVID-19 pandemic. Local surveillance networks may be advantageous in trending community-level RSV activity to optimize prophylaxis administration. Changes in RSV testing patterns occurred throughout the study period and should be accounted for when describing infant and childhood RSV disease.
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Similar articles
-
Respiratory syncytial virus: can we still believe that after pandemic bronchiolitis is not a critical issue for public health?Eur J Pediatr. 2023 Dec;182(12):5303-5313. doi: 10.1007/s00431-023-05201-y. Epub 2023 Sep 20. Eur J Pediatr. 2023. PMID: 37728752 Free PMC article.
-
Clinical Phenotype of Respiratory Syncytial Virus Bronchiolitis before and during the Coronavirus Disease 2019 Pandemic.Am J Perinatol. 2024 Mar;41(4):515-521. doi: 10.1055/s-0042-1759602. Epub 2022 Dec 21. Am J Perinatol. 2024. PMID: 36543242
-
Variation in the seasonality of the respiratory syncytial virus during the COVID-19 pandemic.Infection. 2022 Aug;50(4):1001-1005. doi: 10.1007/s15010-022-01794-y. Epub 2022 Mar 22. Infection. 2022. PMID: 35316529 Free PMC article.
-
Impact of COVID‑19 pandemic restrictions and subsequent relaxation on the prevalence of respiratory virus hospitalizations in children.BMC Pediatr. 2024 Feb 2;24(1):91. doi: 10.1186/s12887-024-04566-9. BMC Pediatr. 2024. PMID: 38302912 Free PMC article. Review.
-
Respiratory syncytial virus bronchiolitis in congenital diaphragmatic hernia: A systematic review of prevalence rates and palivizumab prophylaxis.Pediatr Pulmonol. 2022 Jan;57(1):239-244. doi: 10.1002/ppul.25717. Epub 2021 Oct 12. Pediatr Pulmonol. 2022. PMID: 34617409
Cited by
-
The Impact of COVID-19 Pandemic on Respiratory Syncytial Virus Infection in Children.Pulm Med. 2024 Oct 18;2024:2131098. doi: 10.1155/2024/2131098. eCollection 2024. Pulm Med. 2024. PMID: 39464376 Free PMC article.
-
Group A Streptococcus infections in children and adolescents in the post-COVID-19 era: a regional Italian survey.Ital J Pediatr. 2024 Sep 16;50(1):177. doi: 10.1186/s13052-024-01750-6. Ital J Pediatr. 2024. PMID: 39285296 Free PMC article.
-
Geographic Progression of Infant Respiratory Syncytial Virus Associated Bronchiolitis Across the United States Before and Since the Onset of COVID-19: Results From Four Health Systems, 2015-2023.Influenza Other Respir Viruses. 2024 May;18(5):e13298. doi: 10.1111/irv.13298. Influenza Other Respir Viruses. 2024. PMID: 38751165 Free PMC article.
References
-
- Suh M, Movva N, Jiang X, et al. Respiratory syncytial virus is the leading cause of United States infant hospitalizations, 2009-2019: a study of the national (nationwide) inpatient sample. J Infect Dis. 2022;226:S154–S163.
-
- Rha B, Curns AT, Lively JY, et al. Respiratory syncytial virus–associated hospitalizations among young children: 2015–2016. Pediatrics. 2020;146:e20193611.
-
- Movva N, Suh M, Bylsma LC, et al. Systematic literature review of respiratory syncytial virus laboratory testing practices and incidence in United States infants and children <5 years of age. J Infect Dis. 2022;226:S213–S224.
-
- Movva N, Suh M, Reichert H, et al. Respiratory syncytial virus during the COVID-19 pandemic compared to historic levels: a retrospective cohort study of a health system. J Infect Dis. 2022;226:S175–S183.
-
- Hammitt LL, Dagan R, Yuan Y, et al.; MELODY Study Group. Nirsevimab for prevention of RSV in healthy late-preterm and term infants. N Engl J Med. 2022;386:837–846.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical